Concepedia

Divya Mehta

DM

3

Publications

202

Citations

3

H-Index

2011

Active since

Affiliations

Washington University in St. Louis(Current)

Divya Mehta is an author at Washington University in St. Louis specializing in oncology, drug resistance, and health sciences.

Top concepts

Publications per year

2011–2024

3

Publications

3

A first-in-class, first-in-human, phase I trial of p28, a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in patients with advanced solid tumours

Michael Warso, Jon Richards, Divya Mehta et al. · British Journal of Cancer · 2013 · 177 citations · Full text

Effect of machine learning models on clinician prediction of postoperative complications: the Perioperative ORACLE randomised clinical trial

Bradley A. Fritz, Christopher R. King, Mohamed Abdelhack et al. · British Journal of Anaesthesia · 2024 · 15 citations · Full text

A first-in-class, first-in-human phase I trial of p28, a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in patients with metastatic refractory solid tumors.

Jon Richards, Michael Warso, Divya Mehta et al. · Journal of Clinical Oncology · 2011 · 10 citations

, , +20

Rows per page

1–3 of 3